Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Sparse data analysis

¹Pharmacy Department, University of Manchester, UK.

European Journal of Drug Metabolism and Pharmacokinetics

|January 1, 1993

Summary

This summary is machine-generated.

Manufacturers face pressure to extract more kinetic and dynamic information from sparse data in Phase III clinical trials. This review explores techniques for analyzing sparse data from pharmacokinetic and pharmacodynamic experiments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Constrained numerical deconvolution using orthogonal polynomials.

Heliyon·2024

Same author

Whole body physiologically based modelling of β-blockers in the rat: events in tissues and plasma following an i.v. bolus dose.

British journal of pharmacology·2017

Same author

Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas.

CPT: pharmacometrics & systems pharmacology·2017

Same author

Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.

Clinical pharmacology and therapeutics·2017

Same author

Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients.

Mathematical medicine and biology : a journal of the IMA·2017

Same author

Identification of the effect of multiple polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid using a population-modeling approach.

Clinical pharmacology and therapeutics·2014

Same journal

Population Pharmacokinetic Modeling Study of Glibenclamide in Chinese Healthy Volunteers.

European journal of drug metabolism and pharmacokinetics·2026

Same journal

A Relative Bioavailability Study of Vepdegestrant Tablets in Healthy Adult Participants.

European journal of drug metabolism and pharmacokinetics·2026

Same journal

Population Pharmacokinetics of Amikacin in Non-Neonatal Pediatric Patients: A Scoping Review.

European journal of drug metabolism and pharmacokinetics·2026

Same journal

Investigating the Impact of Calcium Channel Blockers on the Pharmacokinetics of Lapatinib: Possible Role of Cytochrome P450 Enzymes and P-glycoprotein Efflux Transporters.

European journal of drug metabolism and pharmacokinetics·2026

Same journal

Clinical Relevance of the 516 G>T Polymorphism in CYP2B6 and Its Effects on Efavirenz Concentrations in Patients with HIV and Tuberculosis: A Meta-analysis.

European journal of drug metabolism and pharmacokinetics·2026

Same journal

Toxicity-Tailored Thresholds of Delayed Methotrexate Elimination in Non-Hodgkin Lymphoma: A Population-Based Approach to Therapy Optimization.

European journal of drug metabolism and pharmacokinetics·2026

See all related articles

Area of Science:

Pharmacometrics
Clinical Pharmacology
Biostatistics

Background:

Growing interest in analyzing sparse data from Phase III clinical trials.
Increased demand for kinetic and dynamic information from late-stage drug development.
Limitations of traditional methods in handling sparse datasets.

Purpose of the Study:

To review techniques for analyzing sparse data.
To highlight methods applicable to pharmacokinetic and pharmacodynamic studies.
To address the need for richer data interpretation in Phase III trials.

Main Methods:

Review of existing literature on sparse data analysis techniques.
Examples drawn from pharmacokinetic experiments.
Examples drawn from pharmacodynamic experiments.

Related Experiment Videos

Main Results:

Identification of various analytical approaches for sparse data.
Demonstration of applicability in pharmacokinetic and pharmacodynamic contexts.
Emphasis on enhanced information extraction from limited data points.

Conclusions:

Sparse data analysis techniques are crucial for modern drug development.
Pharmacokinetic and pharmacodynamic modeling benefit significantly from these methods.
Manufacturers can gain deeper insights from Phase III trial data.